The Ebola outbreak in eastern DRC has escalated. According to the BBC, the head of Africa CDC reported more than 390 suspected cases and at least 100 deaths, with the WHO formally declaring the situation a public health emergency of international concern. Six Americans are reportedly being evacuated to a quarantine facility, with one possibly symptomatic. Two cases and one death have been confirmed in Uganda. The U.S. has issued its highest-level travel advisory for DRC, and Rwanda has tightened border screening.

The strain driving this outbreak is Bundibugyo, one of the rarer Ebola species. The vaccine that performed so well during the 2018 to 2020 DRC outbreak targets Zaire ebolavirus, not Bundibugyo. There are no licensed vaccines or therapeutics specifically validated against this strain. Response will rely on the older tools: case identification, isolation, contact tracing, safe burial practices, infection prevention in healthcare settings, and supportive care. All of this must be executed in an active conflict zone, with massive population displacement and limited healthcare infrastructure.

We are getting questions about how this compares to the hantavirus situation. Both are serious diseases with high case fatality rates, but the comparison breaks down quickly. Hantavirus spreads primarily through environmental exposure to rodent-contaminated areas. The Andes strain is the only hantavirus with documented human-to-human spread, and what we are seeing on the Hondius appears to be a contained cluster, not evidence of broader community transmissibility. Ebola also does not spread casually, but the conditions that make it efficient (caregiving for severely ill patients, healthcare exposure without adequate PPE, traditional burial practices) are all present in eastern DRC right now, alongside cross-border movement, the Kampala case, and degraded U.S.-supported surveillance infrastructure.

For people in the U.S., neither virus poses meaningful personal risk right now. The DRC outbreak is the more serious story by a wide margin, and it deserves the kind of attention the hantavirus coverage has been receiving.